BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY
To promote education and research in blood and marrow stem cell transplantation and cellular therapy in the UK and Republic of Ireland.
Objects
(A) TO ADVANCE HEALTH BY THE PROMOTION OF RESEARCH INTO AND THE ADVANCEMENT OF KNOWLEDGE OF THE USE OF ALLOGENEIC OR AUTOLOGOUS HAEMOPOIETIC STEM CELLS AND CELLULAR THERAPY IN THE TREATMENT OF LEUKAEMIA, LYMPHOMA, MYELOMA, AND OTHER MALIGNANT DISORDERS, NON-MALIGNANT HAEMATOLOGICAL DISORDERS INCLUDING APLASTIC ANAEMIA AND HAEMOGLOBINOPATHIES AND APPROPRIATE NON HAEMATOLOGICAL DISEASES;
Financial health, per its FY2025 accounts
The accounts state that the charity generated a net incoming resource of £61,847 for the year ended 31 December 2025, increasing its net assets to £539,680. However, the trustees report that free reserves were only £58,305, which is significantly below the stated policy target of £481,375. The trustees acknowledge that static income and rising costs have hindered the society's ability to expand, though they anticipate future growth through commercial partnerships.
What the accounts disclose
“The Trustees have determined that the Society should maintain a minimum level of free reserves equivalent to four months of identified financial liabilities including redundancy costs, amounting to £481,375.” — page 14
“During the year ended 31 December 2025 the charity received income of £45,558 (2024: £42,277) from another charity, Anthony Nolan, in which Dr V T Potter is also a trustee. As at 31 December 2025, £11,437 (2024: £11,246) was due to the charity from Anthony Nolan.” — page 31
Year-over-year changes
- Going concern: going-concern doubt noted (FY2024) → no going-concern doubt (FY2025).
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Paying staff
- Risk management
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 83
- Government income: £224,263 — contracts £224,263 (1); 35% of the £637,663 total gross income on the same return
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 76
- Government income: £200,362 — contracts £200,362 (2); 37% of the £540,723 total gross income on the same return
Self-declared on the annual return for the financial year ending 31/12/2023
- Volunteers: 38
- Government income: £192,200 — grants £192,200 (2); 49% of the £393,699 total gross income on the same return
Structured financials (annual return, FY ending 31/12/2025)
Trustees
- Dr Deborah Susan Richardson
- Dr Fiona Dignan
- Dr Harpreet Kaur
- Dr Victoria Potter
- Prof Eduardo Olavarria
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £638k | £576k |
| 31/12/2024 | £541k | £533k |
| 31/12/2023 | £394k | £460k |
| 31/12/2022 | £376k | £425k |
| 31/12/2021 | £342k | £394k |
Common questions
Is BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a net incoming resource of £61,847 for the year ended 31 December 2025, increasing its net assets to £539,680. However, the trustees report that free reserves were only £58,305, which is significantly below the stated policy target of £481,375. The trustees acknowledge that static income and rising costs have hindered the society's ability to expand, though they anticipate future growth through commercial partnerships. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE COMPANY OF BIOLOGISTS | 1 | £175k |
Charities like this
- THE BRITISH BLOOD TRANSFUSION SOCIETY
- THE BRITISH TRANSPLANTATION SOCIETY
- British Microcirculation and Vascular Biology Society
- BRITISH SOCIETY OF ENDOVASCULAR THERAPY
- BRITISH SOCIETY FOR CELL BIOLOGY
- BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY | £638k | — | 0 | unclear | — | no doubt |
| THE BRITISH BLOOD TRANSFUSION SOCIETY | £281k | — | — | unclear | — | no doubt |
| THE BRITISH TRANSPLANTATION SOCIETY | £774k | — | 0 | above | — | no doubt |
| British Microcirculation and Vascular Biology Society | £27k | — | — | unclear | — | no doubt |
| BRITISH SOCIETY OF ENDOVASCULAR THERAPY | £364k | — | 0 | above | — | no doubt |
| BRITISH SOCIETY FOR CELL BIOLOGY | £138k | — | 0 | unclear | — | no doubt |